Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tevogen Bio Holdings

1.22
-0.0300-2.40%
Post-market: 1.220.00000.00%17:26 EDT
Volume:313.03K
Turnover:381.60K
Market Cap:225.02M
PE:-5.95
High:1.24
Open:1.23
Low:1.20
Close:1.25
Loading ...
Jun 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 23, 2025

Major Issues Report

Form 8-K - Current report
Jun 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 25, 2025

Major Issues Report

Form 8-K - Current report
Apr 18, 2025

Major Issues Report

Form 8-K - Current report
Apr 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 28, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 26, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 01, 2024

Correspondence

Form CORRESP - Correspondence
Jul 31, 2024

Correspondence

Form CORRESP - Correspondence
Jul 29, 2024

Correspondence

Form CORRESP - Correspondence